Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve C Lee

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Oncogene|April 3, 2019
Cancer stem cell self-renewal as a therapeutic target in human oral cancerJinwei Hu, Saied Mirshahidi, Alfred Simental, et al.
Cancer Research|April 3, 2015
CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor PrognosisHyun-Bae Jie, Patrick J Schuler, Steve C Lee, et al.
International Journal of Molecular Sciences|March 29, 2023
Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid CancerSaied Mirshahidi, Isabella J Yuan, Alfred Simental, et al.
Oral Oncology|September 6, 2011
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerAthanassios Argiris, Steve C Lee, Trevor Feinstein, et al.
Cancers|August 10, 2024
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black AmericansSaied Mirshahidi, Isabella J Yuan, Zhong Chen, et al.
Experimental Cell Research|December 24, 2017
Subpopulations of cancer stem cells found in papillary thyroid carcinomaSaied Mirshahidi, Alfred Simental, Steve C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patientsRaghvendra M Srivastava, Steve C Lee, Pedro A Andrade Filho, et al.
Biomarker Research|December 21, 2021
Brush swab as a noninvasive surrogate for tissue biopsies in epigenomic profiling of oral cancerChi T Viet, Xinyu Zhang, Ke Xu, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Advanced Biology|August 4, 2022
Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral CancerColeen Doan, Bradley E Aouizerat, Yi Ye, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Oncogene|April 3, 2019
Cancer stem cell self-renewal as a therapeutic target in human oral cancerJinwei Hu, Saied Mirshahidi, Alfred Simental, et al.
Cancer Research|April 3, 2015
CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor PrognosisHyun-Bae Jie, Patrick J Schuler, Steve C Lee, et al.
International Journal of Molecular Sciences|March 29, 2023
Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid CancerSaied Mirshahidi, Isabella J Yuan, Alfred Simental, et al.
Oral Oncology|September 6, 2011
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerAthanassios Argiris, Steve C Lee, Trevor Feinstein, et al.
Cancers|August 10, 2024
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black AmericansSaied Mirshahidi, Isabella J Yuan, Zhong Chen, et al.
Experimental Cell Research|December 24, 2017
Subpopulations of cancer stem cells found in papillary thyroid carcinomaSaied Mirshahidi, Alfred Simental, Steve C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patientsRaghvendra M Srivastava, Steve C Lee, Pedro A Andrade Filho, et al.
Biomarker Research|December 21, 2021
Brush swab as a noninvasive surrogate for tissue biopsies in epigenomic profiling of oral cancerChi T Viet, Xinyu Zhang, Ke Xu, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Advanced Biology|August 4, 2022
Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral CancerColeen Doan, Bradley E Aouizerat, Yi Ye, et al.
Pageof 4